pyrazinamide has been researched along with Hearing Loss in 3 studies
pyrazinecarboxamide : A monocarboxylic acid amide resulting from the formal condensation of the carboxy group of pyrazinoic acid (pyrazine-2-carboxylic acid) with ammonia. A prodrug for pyrazinoic acid, pyrazinecarboxamide is used as part of multidrug regimens for the treatment of tuberculosis.
Hearing Loss: A general term for the complete or partial loss of the ability to hear from one or both ears.
Excerpt | Relevance | Reference |
---|---|---|
"Gastrointestinal events, hepatitis, hearing impairment, arthralgia, psychosis, hypothyroidism, visual disturbances, giddiness, peripheral neuropathy, skin reactions, swelling or pain at injection site, anorexia and sleep disturbances were important amongst these." | 1.40 | Profile of adverse drug reactions in drug resistant tuberculosis from Punjab. ( Bharti, H; Bhushan, B; Chander, R; Gupta, A; Kajal, NC; Ranga, V, 2014) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bhushan, B | 1 |
Chander, R | 1 |
Kajal, NC | 1 |
Ranga, V | 1 |
Gupta, A | 1 |
Bharti, H | 1 |
Sogebi, OA | 1 |
Adefuye, BO | 1 |
Adebola, SO | 1 |
Oladeji, SM | 1 |
Adedeji, TO | 1 |
Bhalla, RK | 1 |
Jones, TM | 1 |
Rothburn, MM | 1 |
Swift, AC | 1 |
3 other studies available for pyrazinamide and Hearing Loss
Article | Year |
---|---|
Profile of adverse drug reactions in drug resistant tuberculosis from Punjab.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Arthralgia; Ataxia; Chemical and Drug Induced Liver | 2014 |
Clinical predictors of aminoglycoside-induced ototoxicity in drug-resistant Tuberculosis patients on intensive therapy.
Topics: Adult; Age Factors; Aminoglycosides; Antitubercular Agents; Audiometry, Pure-Tone; Body Mass Index; | 2017 |
Tuberculous otitis media -- a diagnostic dilemma.
Topics: Adult; Antitubercular Agents; Diagnosis, Differential; Drug Therapy, Combination; Ear Diseases; Faci | 2001 |